Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Combivent Respimat in Chronic Obstructive Pulmonary Disease (COPD)

NCT00400153 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00400153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00400153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Combivent Respimat in Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
Boehringer Ingelheim
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
Not reported
Enrollment
1,480 (actual)
Sites
180

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive